NL-OMON51038已完成4 期
SARS-CoV2 vaccination and activation of the coagulation system - COCOS
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •- adult patients (age > 18 years)
- •- obtained written informed consent
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study:
- •- patients with Down syndrome
- •- patients with known coagulation disorders
- •- patients on anticoagulants (vitamin K antagonist, low-molecular weight
- •heparin or direct oral anticoagulants)
研究者
相似试验
进行中（未招募）
1 期
SARS-CoV2 vaccination and activation of the clotting systemCoronavirus disease 2019 and thromboembolismEUCTR2021-001655-13-NLRadboudumc40
暂停
不适用
Analysis of the effect of SARS-CoV-2 vaccination in patients with chronic inflammatory diseasesDRKS00024214KSH Kiel/1. medizinische Klinik/Rheumatologie100
招募中
不适用
SARS-CoV-2 (COVID-19) vaccination and the immune responses in patients with haematological malignancy and other immune deficiency.Haematological malignancyImmunosuppressionCOVID-19Blood - Haematological diseasesCancer - Leukaemia - Chronic leukaemiaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphomaCancer - MyelomaInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12622001509752The Perth Blood Institute450
进行中（未招募）
1 期
SARS-Cov-2 vaccine responsiveness in middle-aged and older personsSARS-CoV-19, frailtyEUCTR2021-001976-40-NLational Institute for Public Health and the Environment1,700
招募中
4 期
Monitoring immunogenicity of SARS-Cov-2 vaccination in Dutch middle-aged and older individuals (participating in the Doetinchem Cohort Study)NL-OMON54058Ministerie van Volksgezondheid, Welzijn en Sport (VWS)1,700